http://orcid.org/0000-0003-1379-958X
Figures
Abstract
Background and aim
Overground gait assessment is limited by the analysis of multiple strides or both spatiotemporal gait characteristics, while fixed speed treadmill walking restricts natural gait speed variations. The Gait Real-time Analysis Interactive Lab (GRAIL)-based 6-minute walk test (6MWT) enables 3D motion analysis and self-paced treadmill walking, and could provide insight in gait alterations in patients with chronic obstructive pulmonary disease (COPD). The aim of this study is to compare spatiotemporal gait characteristics between patients with COPD and healthy elderly during the GRAIL-based 6MWT.
Materials and methods
Eighty COPD patients (60% male; 62±7 years; FEV1:56±19% predicted) and 38 healthy elderly (63% male; 62±6 years; FEV1:119±17% predicted) performed two GRAIL-based 6MWTs. Mean differences and coefficient of variation of spatiotemporal gait characteristics were calculated using the trial with the largest walk distance. Sub-analyses were conducted to account for walking speed differences between groups, and muscle strength and COPD severity within the patient group.
Results
COPD patients showed increased temporal gait characteristics, decreased stride and step lengths, and increased gait variability compared to healthy elderly (p<0.01). Stride length variability remained increased in COPD after correction for walking speed (MD:0.98%, CI:0.36–1.61, p = 0.003). Reduced quadriceps strength did not translate into altered gait characteristics, while COPD severity is associated with stride time (left MD:-0.02s, CI:-0.04–0.01, p = 0.003; right MD:-0.02s, CI:-0.04–0.01, p = 0.003).
Discussion
COPD patients performed the GRAIL-based 6MWT differently compared to healthy elderly. Further research should use other variability measures to investigate gait characteristics in COPD, to assess subtle alterations in gait and to enable development of rehabilitation strategies to improve gait, and possibly balance and fall risk in COPD. Other lower limb muscle groups should be considered when investigating gait alterations in COPD.
Citation: Liu W-Y, Spruit MA, Delbressine JM, Willems PJ, Franssen FME, Wouters EFM, et al. (2017) Spatiotemporal gait characteristics in patients with COPD during the Gait Real-time Analysis Interactive Lab-based 6-minute walk test. PLoS ONE 12(12): e0190099. https://doi.org/10.1371/journal.pone.0190099
Editor: Christophe Leroyer, Universite de Bretagne Occidentale, FRANCE
Received: August 30, 2017; Accepted: December 10, 2017; Published: December 28, 2017
Copyright: © 2017 Liu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: The authors received no specific funding for this work.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Patients with chronic obstructive pulmonary disease (COPD) report walking as one of the most problematic activity in daily life [1]. Patients with COPD walk less in daily life [2] and achieve shorter walk distances during the 6-minute walk test (6MWT) compared to healthy subjects [3]. Walking distance is an important parameter in the evaluation of treatment and as a prognostic value, in which walking distances <350 m on the 6MWT are associated with increased mortality [4]. In addition, patients with COPD demonstrate extrapulmonary manifestations affecting the muscular system, resulting in muscular dysfunction [5, 6] and most probably in gait (walking) alterations.
Gait assessment could provide insight in the biomechanical factors associated with the reduced walk distances in patients with COPD. To date, several studies have explored gait in COPD [3, 7–10]. One study reported that gait alterations, such as limping and shuffling, are associated with disease severity in COPD [11]. Patients with COPD also demonstrate decreased cadence, shorter step lengths, increased time spent in double support and a lack of increase in peak ankle dorsiflexion moment after the onset of breathlessness or leg tiredness compared to healthy subjects, while walking at their comfortable speed [7–9]. Increased balance disturbances in mediolateral direction in patients with COPD were observed during the 6MWT [3]. Furthermore, patients with COPD walk with an larger step time and smaller step width variability during fixed speed treadmill [12].
Most studies recorded gait in patients with COPD during overground walking, using accelerometry [3], a pressure sensitive mat [7], 2D or 3D motion capture systems [8, 9]. However, the latter three methods can only assess a limited number of consecutive strides, due to space and/or equipment constraints. Gait analysis using instrumented treadmills could be an alternative to overground gait analysis, as they require less laboratory space [13]. However, treadmill walking at fixed speeds restricts subjects to walk with speed variations, resulting in less natural stride variability. Self-paced treadmill walking, involving a feedback-regulated treadmill that allows subjects to walk at their preferred speed, is suggested to be a suitable alternative to fixed speed treadmill walking in gait analysis [13]. In addition, accelerometry enables the recording of multiple strides, but cannot reliably capture the spatial gait characteristics [14].
The Gait Real-time Analysis Interactive Lab (GRAIL) enables self-paced treadmill walking combined with 3D motion capture and could overcome the limitations in overground and fixed speed treadmill walking. Previous studies observed similar spatiotemporal, kinetic and kinematic gait characteristics in self-paced and fixed speed treadmill walking using the GRAIL system [13, 15]. Moreover, gait speed in self-paced treadmill was comparable to overground walking when using a similar system as the GRAIL [14]. Spatiotemporal gait characteristics can therefore be assessed accurately in patients with COPD over multiple consecutive strides and during exercise testing, such as during a 6MWT. As patients with COPD are able to perform the 6MWT using the GRAIL with minimal differences compared to the overground 6MWT [16], additional outcomes can be obtained to identify gait alterations within this population. In addition, as the 6MWT is a submaximal exercise test, challenging the body to walk at speeds outside of the comfortable walking speed can reveal declines in gait or associations in gait characteristics that are otherwise camouflaged at their comfortable walking speed [17].
The aim of the present study is to compare spatiotemporal gait characteristics between patients with COPD and healthy elderly during the GRAIL-based 6MWT (with and without adjustment for expected differences in walking speed; and within the patient sample after stratification for quadriceps muscle strength or COPD severity, described as the degree of airflow limitation). It was hypothesized that patients with COPD would demonstrate alterations in their spatiotemporal gait characteristics as compared to healthy elderly.
Materials and methods
Study design
This cross-sectional study was conducted in CIRO, a centre of expertise for chronic organ failure in Horn, the Netherlands. Patients with COPD, assessed by spirometry (Carefusion, San Diego, CA, USA) according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria (post-bronchodilator Forced Expiratory Volume in one second /Forced Vital Capacity; FEV1/FVC ratio <0.70), were recruited at regular pre-rehabilitation assessment. Patients with walking aids, chronic oxygen therapy, orthopaedic ailments and/or neuromuscular co-morbidities affecting their walking patterns were excluded, as well as patients with a history of lung cancer, asthma, sarcoidosis, tuberculosis and/or lung surgery. Healthy elderly were recruited amongst healthy subjects who participated in previous trials [18], from co-workers or from healthy relatives of patients. These healthy elderly subjects were included as the non-COPD group (post-bronchodilator FEV1/FVC ratio >0.70), if subjects did not have any self-reported neuromuscular and/or orthopaedic ailments. Spirometry and electrocardiography were conducted prior to the GRAIL-based 6MWT. Then, quadriceps muscle strength was measured (Biodex System 4 Pro, Biodex Medical Systems, Inc., New York, USA). Quadriceps muscle strength was calculated as the peak torque of % predicted, based on Borges et al. [19]. Participants performed thirty volitional maximal contractions at an angular velocity of 90 degrees per second. This study (M13-1374) complied with the Declaration of Helsinki and was approved by the Medical research Ethics Committees United (MEC-U) in the Netherlands. This study is registered at the Dutch Trial Register (NTR4421). Written consent was obtained from all participants.
Assessment of gait
Each participant performed two 6MWT’s using the GRAIL (Motekforce Link, Amsterdam, the Netherlands), a 3D motion capture system with a instrumented dual-belt treadmill and virtual reality on a 180 degrees projection screen (Fig 1). Optical flow of the virtual reality environment was synchronised with the treadmill velocity. Subjects wore tight fitting shorts. Twenty-five reflective markers were placed on anatomical landmarks of each participant according to the Human Body Model (HBM) of the lower limb (Fig 2) [20]. The 3D marker trajectories were collected (100 Hz) with a ten camera 3D motion capture system (Vicon Nexus, Oxford Metrics Ltd., Oxford, UK) and processed in D-flow (Motekforce Link, Amsterdam, the Netherlands). Ground reaction force data from heel contact to toe off were collected using integrated force plates (Forcelink, 12 channels, sample frequency 1000 Hz). Participants were able to self-adjust treadmill speed via a feedback-regulated algorithm in D-flow (Motekforce Link, Amsterdam, the Netherlands). One familiarisation session was performed in order to become accustomed to self-paced treadmill walking and the virtual reality hallway environment. The first GRAIL-based 6MWT was performed after the familiarisation session. Both the familiarisation and the first GRAIL-based 6MWT were conducted during pre-rehabilitation assessment. Patients performed the second GRAIL-based 6MWT between pre-rehabilitation assessment and the first week of pulmonary rehabilitation. Healthy elderly performed two GRAIL-based 6MWTs within one day with at least 45 minutes of rest in between the two tests. Perceived dyspnoea and fatigue were assessed before and after the GRAIL-based 6MWT using a BORG scale. Heart rate and pulse oxygen saturation (SpO2) levels were measured prior and post each GRAIL-based 6MWT using pulse oximetry (Nonin, Care Fusion, San Diego, USA). The instructions of the GRAIL-based 6MWT were provided according to the European Respiratory Society/American Thoracic Society guidelines [21].
Anatomical landmarks are the sternum (STRN), xiphoid (XYPH), navel (NAVE), T10, sacral bone, anterior and posterior superior iliac spine (ASIS and PSIS), greater trochanter of the femur (TROCH), lateral between the greater trochanter and lateral femoral epicondyle (LTHI), lateral epicondyle of the knee (LEK), lateral between the lateral femoral epicondyle and lateral malleolus (ATI), lateral malleoli (LM), heel (HEE), tip of the first metatarsal (TOE) and the fifth metatarsal heads (MT5).
The GRAIL-based 6MWT with the longest walk distance for each subject was used for data processing and analysis. The first 60 seconds of the data were excluded to minimize start-up effects and 15 seconds prior to the end of the test were excluded to minimize deceleration of the treadmill speed towards the end of the test (S1 Appendix). All steps were included for analysis. Gait parameters were determined using a custom program in Matlab (MathWorks Inc., Natick, USA. S2 Appendix). We computed the following spatiotemporal gait characteristics: walking speed (m/s), cadence (steps/min), double support time (s), stride time (s), stride length (m) and step width (m). Step time (s), stance time (s), swing time (s) and step length (m) were computed for left and right separately. Double support time was calculated as the duration of both feet on the force plates. Stride time was calculated as the time from one heel contact to the next ipsilateral heel contact. Stride length was defined as the distance between the toe marker and the ipsilateral toe marker at each heel contact in the anterior-posterior direction. Step width was defined as the distance between the toe marker in mediolateral direction between both feet at heel strike. Step time was calculated as the time from one heel contact to the contralateral heel contact. Stance time was calculated as the duration between heel strike and toe off of the ipsilateral leg. Swing time was calculated as the duration between toe of and heel strike of the ipsilateral leg. Step length was defined as the distance between the toe marker in anteroposterior direction between both feet at heel strike (Fig 3).
To assess the magnitude of variability in spatiotemporal gait characteristics, coefficient of variation ([standard deviation of the gait characteristic divided by the mean] x 100%) was calculated for double support time, stride time, stride length, step width, step time, stance time, swing time and step length. In addition, we included commonly reported parameters of the 6MWT, such as 6MWD, mean walking speed, BORG dyspnoea score, BORG fatigue score, SpO2 level and heart rate.
Statistical analyses
Sample size and power sample size calculations were based on outcomes of Annegarn et al. [3] using the inter-stride trunk acceleration variability of patients with COPD and healthy elderly. Thirty-five participants in each group would provide 90% power at alpha 0.05 (two-tailed) to detect differences between patients with COPD and healthy elderly (63.2±14.0% and 73.7±12.5%, respectively). As spatiotemporal gait characteristics during the GRAIL-based 6MWT have not been assessed, larger sample sizes were used for analyses.
All variables were checked for outliers (S3 Appendix) and normality distribution using the Shapiro Wilk test. Differences between patients with COPD and healthy elderly were studied using independent samples T-tests and non-parametric independent T-tests. A posteriori, the first sub-analysis of 14 patients and 14 healthy elderly with comparable walking distances was performed to assess the differences between the groups independent of walking speed. To assess possible influences of muscular dysfunction on gait, a second sub-analysis was conducted to assess differences in spatiotemporal gait characteristics between patients with low (isokinetic peak torque <70% predicted) and high (isokinetic peak torque >70% predicted) quadriceps muscle strength in COPD. This value corresponded to the cut-off value of 2 standard deviations below the mean isokinetic peak torque for males and females in age group 60 years [19]. In the third sub-analysis, we compared spatiotemporal gait characteristics between patients with mild to moderate COPD (GOLD I-II) and severe to very severe COPD (GOLD III-IV). Mean values, mean differences (MD), standard deviations, coefficients of variation and confidence intervals (CI) were calculated. A p-value below the conventional level of significance (p<0.01) was considered statistically significant. Statistical analyses were performed using SPSS, version 22.0 (IBM, New York, USA).
Results
Demographics
A sample of 80 patients and 38 healthy elderly were analysed for this study. Baseline characteristics of the study population are presented in Table 1. Majority of the patients had moderate to severe COPD.
The GRAIL-based 6MWT and spatiotemporal gait characteristics
Patients with COPD achieved on average a shorter 6MWD compared to healthy elderly (494±80m and 689±64m, p<0.001, respectively, Table 2). Oxygen saturation level decreased significantly during the GRAIL-based 6MWT in patients (-2.7±4.3%, p<0.001) and exercise induced oxygen desaturation was found in 20% of the patients (SpO2nadir ≤ 88%). Patients with COPD showed less increase in heart rate and experienced more dyspnoea and fatigue after the GRAIL-based 6MWT compared to healthy elderly.
Patients with COPD demonstrated decreased cadence compared to healthy elderly (MD: -17.36steps/min, CI:-21.10- -13.61, p<0.001, Table 3). Mean duration of temporal gait characteristics was significantly longer in patients with COPD, while stride length was shorter. No differences were found between left and right spatiotemporal gait characteristics. Patients show increased variability in double support time (MD: 1.18%, CI: 0.69–1.66, p = 0.001), stride length (MD: 1.82%, CI: 1.39–2.25, p<0.001), stance time (left MD: 0.58%, CI: 0.29–0.87, p = 0.002; right MD: 0.57%, CI: 0.28–0.86, p = 0.003), and step length (left MD: 1.77%, CI: 1.32–2.22, p<0.001; right MD: 1.74%, CI:1.29–2.19, p<0.001). Step width variability did not reach a statistical significant difference between the groups (MD: -2.98%, CI: -5.39- -0.57, p = 0.011). The distribution of spatiotemporal gait characteristics for both groups are presented in S4 Appendix.
Sub-analyses
Sub-analysis of 14 patients and 14 healthy elderly subjects with comparable walking distances was performed to assess differences between the groups independent of walking speed (MD: -10.2m, CI: -36.7–16.3, p = 0.437, Table 4). Heart rate, dyspnoea and fatigue scores significantly differed in pre and post exercise testing within each group and between the groups. Mean spatiotemporal gait characteristics in patients with COPD did not differ with healthy elderly. Variability in gait characteristics showed differences in stride length. (MD: 0.98%, CI: 0.35–1.61, p = 0.003) and partly in step length (left MD: 1.07%, CI: 0.36–1.78, p = 0.005; right MD: 1.10%, CI: 0.23–1.97, p = 0.014) between patients and healthy subjects (Table 5). No asymmetry was found between left and right spatiotemporal gait characteristics. Distribution of spatiotemporal gait characteristics for both groups are presented in S5 Appendix.
In the second sub-analysis, the influence of muscular dysfunction on gait characteristics was assessed within the COPD group. Female COPD subjects were less represented in the high quadriceps muscle strength group (n = 8) compared to male COPD subjects in the high muscle strength group (n = 25). Therefore, comparisons between quadriceps muscle strength were conducted for males and females separately (Table 6). Difference in muscle strength in male subjects was -23.64% predicted (CI: -29.7- -17.6, p<0.001) and -29.7% predicted (CI: -35.5 - -24.0, p<0.001) in female subjects. No significant differences in mean spatiotemporal gait characteristics were found between low and high quadriceps muscle strength groups within male and female subjects.
In the third sub-analysis, the influence of the degree of airflow limitation on gait characteristics was assessed within the COPD group. Spatiotemporal gait characteristics were compared between patients with mild-moderate COPD (68.9 ± 1.9% predicted) and severe-very severe COPD (38.0 ± 8.0% predicted; Table 7). Mean swing time was significantly different between the groups (left MD: -0.02s, CI: -0.04- -0.01, p = 0.003; right MD: -0.02s, CI:-0.04–0.01, p = 0.003).
Discussion
This study demonstrates that patients with COPD have different spatiotemporal gait characteristics as compared to healthy elderly during a self-paced treadmill based 6MWT. Patients achieved shorter walk distances with a lower cadence and increased duration of temporal gait characteristics. Patients took shorter steps and showed increased variability in double support time, stride length, stance time and step length. Sub-analysis showed that differences in mean spatiotemporal gait characteristics are mainly attributed to differences in walking speed between the groups. However, variability in stride length remained higher in patients with COPD compared to healthy elderly in the sub-analysis of subject groups with comparable walking speeds. Stratifying patients by quadriceps muscle strength did not distinguish differences in spatiotemporal gait characteristics. Patients with mild-moderate COPD showed decreased swing time as compared to severe-very severe COPD.
This is the first study to investigate spatiotemporal gait characteristics during a self-paced treadmill based 6MWT in patients with COPD using the GRAIL. Walking speed and cadence were decreased in patients with COPD, which is in line with previous studies [3, 22, 23]. Reduced gait speed and cadence could reflect respiratory limitations associated with muscular dysfunction in COPD [22, 24, 25]. These gait alterations might be an adaptation mechanism to cope with impaired walking endurance due to the lack of oxygen supply and lower limb muscle weakness. Taking slower steps decreases the oxygen demands of the leg muscles and thus allows for increased walking distance in patients with impaired lung function [26]. Increased step width could be an adaptation to increase the base of support during the double support phase of gait [9]. However, our results did not support differences in step width between patients with COPD and healthy elderly.
Increased variability in double support time, stride length, stance time and step length were found in patients with COPD as compared to healthy elderly. These findings show that patients are less consistent in their walking pattern during the GRAIL-based 6MWT. Step length and stance time variability are increased in older adult fallers as compared to older adult non-fallers [27, 28]. Increased gait variability in COPD could therefore be associated with an increased fall risk within this population. Decreased step width variability in patients with COPD as compared to healthy elderly subjects did not reach a statistical significant difference. However, Yentes et al. [12] suggested that reduced variability in step width may be related to an increased likelihood to a crossover gait. This might indicate that patients are less able to maintain stability, thus predisposing an individual to a fall [29, 30].
Variability in spatiotemporal gait characteristics was calculated as the coefficient of variation, describing the magnitude of variation in each spatiotemporal gait characteristic. When examining the individual variations per gait characteristic, differences between the two groups are observed. However, these differences are cancelled out when comparing the mean values in a subgroup with similar walking speeds. Therefore, other measures that do take the temporal structure of variation into account could provide additional insight into the control of the system while walking [31–34]. Future research might investigate temporal fluctuations of gait characteristics in patients with COPD, to determine subtle alterations in gait in patients with COPD and its associations with fall risk.
The first sub-analysis showed increased variability in stride length in patients with COPD compared to healthy elderly, which indicates that patients with COPD are more variable in their stride lengths irrespective of walking speed differences. Patients with COPD seem to display a larger distribution of variability in their gait characteristics as compared to healthy elderly when walking at similar walking speeds. These patients experienced greater elevated heart rates and report higher dyspnoea and fatigue scores for both pre and post values compared to healthy elderly. These findings direct to the systemic consequences of COPD, resulting in muscular dysfunction and deconditioning [5, 35], in which pulmonary rehabilitation has proven to enhance exercise performance in patients with COPD [36]. Patients with COPD are more susceptible to fatigue [37], possibly explaining the increased fatigue scores in our patients as compared to healthy elderly. Gait alterations in patients with COPD could result in decreased exercise capacity and increased symptoms after the 6MWT. Therefore, gait training could be incorporated within pulmonary rehabilitation programs to improve walking ability and symptoms after exercise testing in COPD.
Previous literature reported correlations between the severity of the disease and functional exercise capacity [38, 39]. However, the current study does not provide evidence for influences of COPD severity on spatiotemporal gait characteristics. Airflow limitation might not have translated to alterations in mean spatiotemporal gait characteristics in COPD. This could be explained by that patients were mostly diagnosed as GOLD II (moderate) and III (severe), whereas patients with GOLD I (mild) and IV (very severe) were less represented in the disease severity groups. Skeletal muscle dysfunction, in particular the quadriceps, is well recognized in COPD and is associated with impaired functional capacity, such as the 6MWT [40, 41]. Our results however did not support differences in spatiotemporal gait characteristics between patients with low and high quadriceps muscle strength. A possible explanation could be that reduced quadriceps muscle strength is not directly related to impaired spatiotemporal gait characteristics in COPD. Alternatively, more distal located lower limb muscles might be more appropriate to be associated with gait characteristics. Previous studies have demonstrated the importance of the triceps surae for propulsion during gait [42–45]. Weakness in ankle dorsiflexors and plantarflexors has been reported to be greater than weakness present in the quadriceps of patients with COPD [46, 47]. In addition, patients with COPD demonstrate a lack of increase in peak ankle dorsiflexion moment after a fatiguing treadmill protocol [9]. Patients with COPD might therefore experience problems in lowering their forefoot after heel strike. Future studies may examine the association between decreased muscle strength in other muscle groups in the lower limbs and altered gait characteristics.
The current study has some limitations. First, subjects walked on a motorized treadmill, which may impede natural walking pattern and its variability. However, previous studies have reported equivocal findings [48–50]. Self-paced treadmill walking was used to provide a more natural control of the walking speed [14, 51], while virtual reality environment could have created a more realistic environment due to the use of a virtual environment enabling optic flow [15]. In addition, self-paced treadmill walking has been validated for healthy subjects during comfortable walking speed [14, 51]. Second, the sample size of female patients in the high quadriceps muscle strength group is small. Consequently, these subjects might not be a comprehensive representation of female patients within the high muscle strength group.
In conclusion, patients with COPD have different spatiotemporal gait characteristics during a self-paced treadmill 6MWT compared to healthy elderly as assessed by the GRAIL. Independent of walking speed, patients with COPD show increased stride length variability during the GRAIL-based 6MWT. Reduced quadriceps strength does not translate into altered spatiotemporal gait characteristics, while COPD severity has impact on swing time. Further research should investigate gait characteristics in patients with COPD using other variability measures, to assess subtle alterations in gait and to enable development of rehabilitation strategies to improve gait, and possibly balance and fall risk in these patients. In addition, other muscle groups in the lower limbs should be taken into account when investigating gait alterations in COPD.
Supporting information
S2 Appendix. Data correction and event detection.
https://doi.org/10.1371/journal.pone.0190099.s002
(PDF)
S3 Appendix. Heterogeneity in COPD and healthy elderly group.
https://doi.org/10.1371/journal.pone.0190099.s003
(PDF)
S4 Appendix. Boxplots of spatiotemporal gait characteristics in the total sample.
https://doi.org/10.1371/journal.pone.0190099.s004
(PDF)
S5 Appendix. Boxplots of spatiotemporal gait characteristics in the sub-analysis.
https://doi.org/10.1371/journal.pone.0190099.s005
(PDF)
References
- 1. Annegarn J, Meijer K, Passos VL, Stute K, Wiechert J, Savelberg HH, et al. Problematic activities of daily life are weakly associated with clinical characteristics in COPD. Journal of the American Medical Directors Association. 2012;13(3):284–90. Epub 2011/04/01. pmid:21450242.
- 2. Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine. 2005;171(9):972–7. Epub 2005/01/25. pmid:15665324.
- 3. Annegarn J, Spruit MA, Savelberg HH, Willems PJ, van de Bool C, Schols AM, et al. Differences in walking pattern during 6-min walk test between patients with COPD and healthy subjects. PloS one. 2012;7(5):e37329. Epub 2012/05/25. pmid:22624017; PubMed Central PMCID: PMC3356256.
- 4. Spruit MA, Polkey MI, Celli B, Edwards LD, Watkins ML, Pinto-Plata V, et al. Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease. Journal of the American Medical Directors Association. 2012;13(3):291–7. pmid:21778120.
- 5. Gosker HR, van Mameren H, van Dijk PJ, Engelen MP, van der Vusse GJ, Wouters EF, et al. Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease. The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology. 2002;19(4):617–25. pmid:11998989.
- 6. Wouters EF. Chronic obstructive pulmonary disease. 5: systemic effects of COPD. Thorax. 2002;57(12):1067–70. pmid:12454303; PubMed Central PMCID: PMC1758796.
- 7. Lahousse L, Verlinden VJ, van der Geest JN, Joos GF, Hofman A, Stricker BH, et al. Gait patterns in COPD: the Rotterdam Study. The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology. 2015;46(1):88–95. pmid:25700390.
- 8. Nantsupawat N, Lane P, Siangpraipunt O, Gadwala S, Nugent K. Gait Characteristics in Patients With Chronic Obstructive Pulmonary Disease. Journal of primary care & community health. 2015;6(4):222–6. pmid:25801202.
- 9. Yentes JM, Schmid KK, Blanke D, Romberger DJ, Rennard SI, Stergiou N. Gait mechanics in patients with chronic obstructive pulmonary disease. Respiratory research. 2015;16:31. pmid:25849481; PubMed Central PMCID: PMC4351940.
- 10. Yentes JM, Rennard SI, Schmid KK, Blanke D, Stergiou N. Patients with COPD Walk with Altered Step Time and Step Width Variability as Compared to Healthy Controls. Annals of the American Thoracic Society. 2017. pmid:28267374.
- 11. Yentes JM, Sayles H, Meza J, Mannino DM, Rennard SI, Stergiou N. Walking abnormalities are associated with COPD: An investigation of the NHANES III dataset. Respiratory medicine. 2011;105(1):80–7. Epub 2010/07/10. pmid:20615681.
- 12. Yentes JM, Rennard SI, Schmid KK, Blanke D, Stergiou N. Patients with Chronic Obstructive Pulmonary Disease Walk with Altered Step Time and Step Width Variability as Compared with Healthy Control Subjects. Annals of the American Thoracic Society. 2017;14(6):858–66. pmid:28267374.
- 13. Sloot LH, van der Krogt MM, Harlaar J. Self-paced versus fixed speed treadmill walking. Gait & posture. 2014;39(1):478–84. pmid:24055003.
- 14. Plotnik M, Azrad T, Bondi M, Bahat Y, Gimmon Y, Zeilig G, et al. Self-selected gait speed—over ground versus self-paced treadmill walking, a solution for a paradox. Journal of neuroengineering and rehabilitation. 2015;12:20. pmid:25881130; PubMed Central PMCID: PMC4374285.
- 15. Sloot LH, van der Krogt MM, Harlaar J. Effects of adding a virtual reality environment to different modes of treadmill walking. Gait & posture. 2014;39(3):939–45. pmid:24412269.
- 16. Liu WY, Meijer K, Delbressine JM, Willems PJ, Franssen FM, Wouters EF, et al. Reproducibility and Validity of the 6-Minute Walk Test Using the Gait Real-Time Analysis Interactive Lab in Patients with COPD and Healthy Elderly. PloS one. 2016;11(9):e0162444. pmid:27607426; PubMed Central PMCID: PMC5015964.
- 17. Helbostad JL, Moe-Nilssen R. The effect of gait speed on lateral balance control during walking in healthy elderly. Gait & posture. 2003;18(2):27–36. pmid:14654205.
- 18. Rutten EP, Gopal P, Wouters EF, Franssen FM, Hageman GJ, Vanfleteren LE, et al. Various Mechanistic Pathways Representing the Aging Process Are Altered in COPD. Chest. 2016;149(1):53–61. pmid:26066545.
- 19. Borges O. Isometric and isokinetic knee extension and flexion torque in men and women aged 20–70. Scandinavian journal of rehabilitation medicine. 1989;21(1):45–53. pmid:2711137.
- 20. van den Bogert AJ, Geijtenbeek T, Even-Zohar O, Steenbrink F, Hardin EC. A real-time system for biomechanical analysis of human movement and muscle function. Medical & biological engineering & computing. 2013;51(10):1069–77. pmid:23884905; PubMed Central PMCID: PMC3751375.
- 21. Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology. 2014;44(6):1428–46. pmid:25359355.
- 22. Butcher SJ, Meshke JM, Sheppard MS. Reductions in functional balance, coordination, and mobility measures among patients with stable chronic obstructive pulmonary disease. Journal of cardiopulmonary rehabilitation. 2004;24(4):274–80. Epub 2004/08/03. pmid:15286536.
- 23. Menard-Rothe K, Sobush DC, Bousamra M 2nd, Haasler , Lipchik RJ. Self-selected walking velocity for functional ambulation in patients with end-stage emphysema. Journal of cardiopulmonary rehabilitation. 1997;17(2):85–91. Epub 1997/03/01. pmid:9101385.
- 24. Roig M, Eng JJ, MacIntyre DL, Road JD, FitzGerald JM, Burns J, et al. Falls in people with chronic obstructive pulmonary disease: an observational cohort study. Respiratory medicine. 2011;105(3):461–9. pmid:20869227; PubMed Central PMCID: PMC3350813.
- 25. Mador MJ, Krauza M, Shaffer M. Effect of exercise training in patients with chronic obstructive pulmonary disease compared with healthy elderly subjects. Journal of cardiopulmonary rehabilitation and prevention. 2012;32(3):155–62. pmid:22487615.
- 26. Roig M, Eng JJ, Road JD, Reid WD. Falls in patients with chronic obstructive pulmonary disease: a call for further research. Respiratory medicine. 2009;103(9):1257–69. Epub 2009/05/08. pmid:19419852; PubMed Central PMCID: PMC3326069.
- 27. Mbourou GA, Lajoie Y, Teasdale N. Step length variability at gait initiation in elderly fallers and non-fallers, and young adults. Gerontology. 2003;49(1):21–6. doi: 66506. pmid:12457046.
- 28. Hausdorff JM, Edelberg HK, Mitchell SL, Goldberger AL, Wei JY. Increased gait unsteadiness in community-dwelling elderly fallers. Archives of physical medicine and rehabilitation. 1997;78(3):278–83. pmid:9084350.
- 29. Gabell A, Nayak US. The effect of age on variability in gait. Journal of gerontology. 1984;39(6):662–6. pmid:6491179.
- 30. Maki BE. Gait changes in older adults: predictors of falls or indicators of fear. Journal of the American Geriatrics Society. 1997;45(3):313–20. pmid:9063277.
- 31. Hausdorff JM. Gait dynamics, fractals and falls: finding meaning in the stride-to-stride fluctuations of human walking. Human movement science. 2007;26(4):555–89. Epub 2007/07/10. pmid:17618701; PubMed Central PMCID: PMC2267927.
- 32. Hausdorff JM, Mitchell SL, Firtion R, Peng CK, Cudkowicz ME, Wei JY, et al. Altered fractal dynamics of gait: reduced stride-interval correlations with aging and Huntington's disease. J Appl Physiol (1985). 1997;82(1):262–9. pmid:9029225.
- 33. Toebes MJ, Hoozemans MJ, Furrer R, Dekker J, van Dieen JH. Local dynamic stability and variability of gait are associated with fall history in elderly subjects. Gait & posture. 2012;36(3):527–31. pmid:22748312.
- 34. Stergiou N, Harbourne R, Cavanaugh J. Optimal movement variability: a new theoretical perspective for neurologic physical therapy. Journal of neurologic physical therapy: JNPT. 2006;30(3):120–9. pmid:17029655.
- 35. Gea J, Pascual S, Casadevall C, Orozco-Levi M, Barreiro E. Muscle dysfunction in chronic obstructive pulmonary disease: update on causes and biological findings. Journal of thoracic disease. 2015;7(10):E418–38. pmid:26623119; PubMed Central PMCID: PMC4635259.
- 36. Barreiro E, Bustamante V, Cejudo P, Galdiz JB, Gea J, de Lucas P, et al. Guidelines for the evaluation and treatment of muscle dysfunction in patients with chronic obstructive pulmonary disease. Archivos de bronconeumologia. 2015;51(8):384–95. pmid:26072153.
- 37. Donaldson AV, Maddocks M, Martolini D, Polkey MI, Man WD. Muscle function in COPD: a complex interplay. International journal of chronic obstructive pulmonary disease. 2012;7:523–35. pmid:22973093; PubMed Central PMCID: PMC3430120.
- 38. Agrawal MB, Awad NT. Correlation between Six Minute Walk Test and Spirometry in Chronic Pulmonary Disease. Journal of clinical and diagnostic research: JCDR. 2015;9(8):OC01–4. pmid:26435980; PubMed Central PMCID: PMC4576573.
- 39. Wijkstra PJ, TenVergert EM, van der Mark TW, Postma DS, Van Altena R, Kraan J, et al. Relation of lung function, maximal inspiratory pressure, dyspnoea, and quality of life with exercise capacity in patients with chronic obstructive pulmonary disease. Thorax. 1994;49(5):468–72. pmid:8016768; PubMed Central PMCID: PMC474868.
- 40. Gosker HR, Wouters EF, van der Vusse GJ, Schols AM. Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. The American journal of clinical nutrition. 2000;71(5):1033–47. pmid:10799364.
- 41. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. American journal of respiratory and critical care medicine. 1996;153(3):976–80. pmid:8630582.
- 42. Liu MQ, Anderson FC, Schwartz MH, Delp SL. Muscle contributions to support and progression over a range of walking speeds. Journal of biomechanics. 2008;41(15):3243–52. pmid:18822415; PubMed Central PMCID: PMC4423744.
- 43. Murray MP, Guten GN, Sepic SB, Gardner GM, Baldwin JM. Function of the triceps surae during gait. Compensatory mechanisms for unilateral loss. The Journal of bone and joint surgery American volume. 1978;60(4):473–6. pmid:670268.
- 44. Requiao LF, Nadeau S, Milot MH, Gravel D, Bourbonnais D, Gagnon D. Quantification of level of effort at the plantarflexors and hip extensors and flexor muscles in healthy subjects walking at different cadences. Journal of electromyography and kinesiology: official journal of the International Society of Electrophysiological Kinesiology. 2005;15(4):393–405. pmid:15811610.
- 45. Sutherland DH, Cooper L, Daniel D. The role of the ankle plantar flexors in normal walking. The Journal of bone and joint surgery American volume. 1980;62(3):354–63. pmid:7364808.
- 46. Gagnon P, Maltais F, Bouyer L, Ribeiro F, Coats V, Brouillard C, et al. Distal leg muscle function in patients with COPD. Copd. 2013;10(2):235–42. pmid:23547635.
- 47. Maddocks M, Jones M, Snell T, Connolly B, de Wolf-Linder S, Moxham J, et al. Ankle dorsiflexor muscle size, composition and force with ageing and chronic obstructive pulmonary disease. Experimental physiology. 2014;99(8):1078–88. pmid:24928952.
- 48. Lee SJ, Hidler J. Biomechanics of overground vs. treadmill walking in healthy individuals. J Appl Physiol (1985). 2008;104(3):747–55. Epub 2007/12/01. pmid:18048582.
- 49. Riley PO, Paolini G, Della Croce U, Paylo KW, Kerrigan DC. A kinematic and kinetic comparison of overground and treadmill walking in healthy subjects. Gait & posture. 2007;26(1):17–24. pmid:16905322.
- 50. Alton F, Baldey L, Caplan S, Morrissey MC. A kinematic comparison of overground and treadmill walking. Clinical biomechanics. 1998;13(6):434–40. pmid:11415818.
- 51. Sloot LH, van der Krogt MM, Harlaar J. Self-paced versus fixed speed treadmill walking. Gait & posture. 2013. Epub 2013/09/24. pmid:24055003.